-
Information-Publications
-
One‐Pot Controllable Assembly of a Baicalin‐Condensed Aptamer Nanodrug for Synergistic Anti‐ObesityDetails
-
An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved …Details
-
Two compact Cas9 ortholog-based cytosine base editors expand the DNA targeting scope and applications in vitro and in vivoDetails
-
A novel base editor SpRY-ABE8eF148A mediates efficient A-to-G base editing with a reduced off-target effectDetails
-
Mir155 regulates osteogenesis and bone mass phenotype via targeting S1pr1 geneDetails
-
Cezanne contributes to cancer progression by playing a key role in the deubiquitination of IGF-1RDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands